Literature DB >> 17071133

Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.

Simon Florian Preuss1, Vera Dinh, Jens Peter Klussmann, Robert Semrau, Rolf-Peter Mueller, Orlando Guntinas-Lichius.   

Abstract

The clinical management of patients with primary oropharyngeal squamous cell carcinoma remains controversial. The results of a combined approach involving surgery for the primary tumor, neck dissection, and postoperative radiotherapy were reviewed. A retrospective review was carried out for 211 patients meeting the inclusion criteria of resectable squamous cell carcinoma of the oropharynx. Overall survival and disease-free survival rates were calculated using the Kaplan-Meier method. Univariate (Log-rank test) and multivariate (Cox proportional hazards models) statistical analyses were carried out to investigate the role of clinical factors as significant prognostic markers. The 2- and 5-year disease-free survival rates were 79.8% and 68.8%, respectively. In univariate and multivariate analyses, positive resection margins were the only and independent significant prognostic markers for impaired disease-free survival (Log-rank: p=0.0238; Cox model: p=0.045; hazard ratio 2.48 [95% confidence interval 1.02-6.05]). In univariate analysis, male sex was the only significant negative prognostic factor for overall survival (Log-rank: p=0.0453), whereas Cox multivariate analysis identified extracapsular spread as an independent prognostics marker (p=0.049; hazard ratio 1.86 [95% confidence interval 1.00-3.43]). We conclude that the presented multimodal approach of surgery for the primary tumor and the neck followed by postoperative radio(chemo)therapy seems to be superior to non-surgical treatment protocols, as it results in better disease-free and overall survival. To assess this multimodal treatment approach, morbidity and economic considerations need to be further analyzed.

Entities:  

Mesh:

Year:  2006        PMID: 17071133     DOI: 10.1016/j.oraloncology.2006.04.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

Review 1.  [Update on HPV-induced oropharyngeal cancer].

Authors:  S F Preuss; J-P Klussmann; R Semrau; C Huebbers
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

Review 2.  Robotic surgery for oropharynx cancer: promise, challenges, and future directions.

Authors:  John R de Almeida; Eric M Genden
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.

Authors:  Robert Semrau; Susanne Temming; Simon Florian Preuss; Jens Peter Klubmann; Orlando Guntinas-Lichius; Rolf-Peter Müller
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

4.  Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma.

Authors:  James S Lewis; Danielle H Carpenter; Wade L Thorstad; Qin Zhang; Bruce H Haughey
Journal:  Mod Pathol       Date:  2011-06-24       Impact factor: 7.842

5.  Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.

Authors:  Fred M Baik; Stacey Hansen; Sue E Knoblaugh; Disha Sahetya; Ryan M Mitchell; Chang Xu; James M Olson; Julia Parrish-Novak; Eduardo Méndez
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-04       Impact factor: 6.223

6.  Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer.

Authors:  Julian Künzel; Georgios Psychogios; Konstantinos Mantsopoulos; Philipp Grundtner; Frank Waldfahrer; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

7.  Expression of podoplanin and prognosis in oropharyngeal cancer.

Authors:  Simon F Preuss; Andreas Anagiotos; Inga M C Seuthe; Uta Drebber; Inga Wedemeyer; Matthias Kreppel; Robert Semrau; Guy D Eslick; Jens Peter Klussmann; Christian U Huebbers
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-01       Impact factor: 2.503

8.  Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer.

Authors:  S F Preuss; A Weinell; M Molitor; M Stenner; R Semrau; U Drebber; S J Weissenborn; E J M Speel; C Wittekindt; O Guntinas-Lichius; T K Hoffmann; G D Eslick; J P Klussmann
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.